Gensight Biologics S.A.
SIGHTFR0013183985
GenSight Biologics est une société française qui développe des thérapies géniques pour des maladies de l’œil. À fin 2019, la société dispose d'un portefeuille de 2 produits, dont le plus avancé est celui pour le traitement de la neuropathie optique héréditaire de Leber (NOHL).
Filings
109 filings
- Inside Information / News release on accounts, resultsInside informationFR
- Franchissement de seuilsThreshold crossingFrench
- Inside Information / Other news releasesInside informationFR
- Inside Information / Other news releasesInside informationFR
- Inside Information / Other news releasesInside informationFR
- Inside Information / Other news releasesInside informationFR
- URD 2025Universal registration document
- Inside Information / News release on accounts, resultsInside informationFR
- Inside Information / News release on accounts, resultsInside informationFR
- Inside Information / News release on accounts, resultsInside informationFR
- Franchissement de seuilsThreshold crossingFrench
- Inside Information / Other news releasesInside informationFR
- Inside Information / Other news releasesInside informationFR
- Franchissement de seuilsThreshold crossingFrench
- Inside Information / News release on accounts, resultsInside informationFR
- Inside Information / Other news releasesInside informationFR
- Inside Information / Other news releasesInside informationFR
- Inside Information / Other news releasesInside informationFR
- Inside Information / Other news releasesInside informationFR
- Franchissement de seuilsThreshold crossingFrench
- Inside Information / News release on accounts, resultsInside informationFR
- Inside Information / Other news releasesInside informationFR
- Inside Information / Other news releasesInside informationFR
- Inside Information / Other news releasesInside informationFR
- Inside Information / Other news releasesInside informationFR
- Inside Information / Other news releasesInside informationFR
- Franchissement de seuilsThreshold crossingFrench
- Inside Information / Other news releasesInside informationFR
- Franchissement de seuilsThreshold crossingFrench
- Inside Information / Other news releasesInside informationFR
- Inside Information / Other news releasesInside informationFR
- Inside Information / News release on accounts, resultsInside informationFR
- Inside Information / Other news releasesInside informationFR
- Inside Information / News release on accounts, resultsInside informationFR
- rapport financier semestriel 2025Half-year financial report
- Inside Information / Other news releasesInside informationFR
- Inside Information / Other news releasesInside informationFR
- Inside Information / Operations of the issuer (acquisitions, sales...)Inside informationFR
- Inside Information / Other news releasesInside informationFR
- Inside Information / Operations of the issuer (acquisitions, sales...)Inside informationFR
- Franchissement de seuilsThreshold crossingFrench
- Inside Information / News release on accounts, resultsInside informationFR
- Inside Information / Operations of the issuer (acquisitions, sales...)Inside informationFR
- Informations privilégiées / Opérations de l'émetteur (acquisitions, cessions...)Inside informationFrench
About
- ISIN
- FR0013183985
- Ticker
- SIGHT
- LEI
- 549300NK4AB8OUEX1F54
- Founded
- 2012
- Country of registration
- FR
- Last filing
- 08/07/2026, 19:11
Description from Wikidata, CC0 licence.
Filing history
Filings per month
13
Sept 23May 24Jan 25Sept 25Aug 26
Document types
Across the whole archive